Cyberknife® stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24 months

MLA

Véronique Beckendorf, et al. “Cyberknife® Stereotactic Radiation Therapy for Stage I Lung Cancer and Pulmonary Metastases: Evaluation of Local Control at 24 Months.” Journal of Thoracic Disease, vol. 10, Aug. 2018, pp. 4976–84. EBSCOhost, https://doi.org/10.21037/jtd.2018.07.26.

APA

Véronique Beckendorf, Julia Salleron, Didier Peiffert, Myriam Khadige, Vincent Marchesi, & Guillaume Oldrini. (2018). Cyberknife® stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24 months. Journal of Thoracic Disease, 10, 4976–4984. https://doi.org/10.21037/jtd.2018.07.26

Chicago

Véronique Beckendorf, Julia Salleron, Didier Peiffert, Myriam Khadige, Vincent Marchesi, and Guillaume Oldrini. 2018. “Cyberknife® Stereotactic Radiation Therapy for Stage I Lung Cancer and Pulmonary Metastases: Evaluation of Local Control at 24 Months.” Journal of Thoracic Disease 10 (August): 4976–84. doi:10.21037/jtd.2018.07.26.